Company Snapshot: Uncategorized

Most Hemispherx Biopharma (HEB) shareholders must be feeling sick after being on a rollercoaster ride an entire week. The stock went up and down and traded more than 90 million shares only to finish 1 cent below where it closed last Friday. Two months ago, barely 200,000 shares changed hands in a week’s time. On Tuesday, the Company announced a […]

On Monday, our favorite biotech stock Hemispherx Biopharma (HEB), announced that it had agreed to sell up to $18.3 million in common stock and warrants in a registered offering to two institutional investors. In return for $15 million cash, the new investors received common shares of HEB’s stock at $1.10 per share. Additionally, they will receive Series A warrants to […]

Our original interest with Hemispherx Biopharma (HEB) was the fact that one of its experimental products was under active review with the United States Food and Drug Administration for the treatment of Chronic Fatigue Syndrome. However, our interest in today’s interview is to discuss the recent events of the spread of swine influenza that is all over the news in […]

The World Health Organization (WHO) will hold an emergency meeting today (Saturday, April 25, 2009) to discuss a deadly swine flu strain outbreak in Mexico and the United States. The WHO’s director-general, Margaret Chan, said the outbreak of the never-before-seen virus is a very serious situation and has “pandemic potential.” But she said it is still too early to tell […]

On Wednesday, Orsus Xelent Technologies, Inc. (ORS), a designer and manufacturer of mobile phones for the Asian market, announced its full year 2008 results. Revenues for the full year ended December 31, 2008 grew approximately 20% to $107,827,000, compared with $89,923,000 in 2007. Full year net income grew 16.6% to $11,296,000 or $.38 per share, compared with $9,683,000 or $0.33 […]

Does the board of Orsus Xelent Technologies Inc. (ORS) read my posts? In my post last week, I wrote that Orsus, a designer and manufacturer of award-winning mobile phones for the Asian market, was my only disappointment so far this year. And what do you know? On Thursday the Company announced a big management shift. Mr. Xin Wang, CEO and […]

On Wednesday, James Reindl, Chairman, Director and CEO of TechPrecision Corp. (TPCS) resigned. The press release stated: “Mr. Reindl submitted his resignation and confirmed that despite briefly attending the University of Delaware, he did not receive a degree from the University of Delaware as he had previously represented.” When I visited the TPCS website, Mr. Reindl’s profile was already gone. […]

Last week, Dr. Strayer, Hemispherx Biopharma’s (NYSE Alternext US: HEB) Medical Director, presented new cytokine and cardiovascular data at the 9th International IACFS/ME conference. This week, Dr. Strayer and Dr Carter, Hemispherx’ CEO, held a conference call in which they gave an update on the Company’s FDA progress and the new released data. In my previous Hemispherx update, which was […]

Earlier in the week, Boots & Coots International Well Control, Inc. (NYSE Alternext US: WEL) reported very strong fourth quarter and year end results. Revenues for 2008 increased 99% to $209.2 million compared to $105.3 million for the prior year. Net income attributable to common stockholders increased 177% to $21.8 million, or $0.28 per diluted share, compared to $7.9 million, […]

Renewable energy Companies come in different shapes and sizes. Some focus on wind or solar power, while others produce energy from geothermal or biomass waste sources. By now, everybody agrees, there’s a limited amount of fossil fuels available on Earth. So gradually, alternative energy will be our only source for energy production. That’s why we’ve seen a real boom of […]